This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

Back

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Topics Sessions Videos Previous meetings

CLL - 662

Retreatment With Venetoclax-Based Therapies in Relapsed Chronic Lymphocytic Leukemia: A Pool Analysis of Outcomes Based on Treatment-Free Intervals and Cytogenetics/Molecular Risks

Preview of Retreatment With Venetoclax-Based Therapies in Relapsed Chronic Lymphocytic Leukemia: A Pool Analysis of Outcomes Based on Treatment-Free Intervals and Cytogenetics/Molecular Risks

View Poster Contact Presenter

Poster Presenter

Jun Chih Wang

Authors

Jun Chih Wang

Part of Topic

Chronic Lymphocytic Leukemia (CLL)

CLL-662

Retreatment With Venetoclax-Based Therapies in Relapsed Chronic Lymphocytic Leukemia: A Pooled Analysis of Outcomes Based on Treatment-Free Intervals and Cytogenetic/Molecular Risks

Other ePosters in

Topic

CLL - 009Application of CRISPR-Cas9 Technology in the Treatment of Chronic Lympho...

CLL - 010Abnormal Apoptosis of Autoimmunity From Chronic Lymphocytic Leukemia

CLL - 046Predictors and Outcomes of Major Cardiovascular Events in Hospitalized C...

CLL - 065Frequency of Chromosome 11q22-q23 Deletion in Pakistani Patients With Ch...

CLL - 074Baseline Monocyte-Macrophage Exhaustion and NK-Cell Dysfunction Could Pr...

ePosters in

Topics

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)